7.10Open5.90Pre Close10 Volume87 Open Interest88.00Strike Price7.43KTurnover0.00%IV0.30%PremiumMay 9, 2025Expiry Date8.96Intrinsic Value100Multiplier2DDays to Expiry0.24Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.93Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet